NM_015330.6:c.3293G>A
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PM2PP5_Very_Strong
The NM_015330.6(SPECC1L):c.3293G>A(p.Arg1098Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_015330.6 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SPECC1L | NM_015330.6 | c.3293G>A | p.Arg1098Gln | missense_variant | Exon 17 of 17 | ENST00000314328.14 | NP_056145.5 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SPECC1L | ENST00000314328.14 | c.3293G>A | p.Arg1098Gln | missense_variant | Exon 17 of 17 | 1 | NM_015330.6 | ENSP00000325785.8 | ||
| SPECC1L-ADORA2A | ENST00000358654.2 | n.*679G>A | non_coding_transcript_exon_variant | Exon 18 of 20 | 2 | ENSP00000351480.2 | ||||
| SPECC1L-ADORA2A | ENST00000358654.2 | n.*679G>A | 3_prime_UTR_variant | Exon 18 of 20 | 2 | ENSP00000351480.2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:3
Not observed in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 31953237, 30472488) -
- -
- -
Teebi hypertelorism syndrome 1 Pathogenic:2
- -
- -
Teebi hypertelorism syndrome Pathogenic:1
- -
SPECC1L-related syndrome Pathogenic:1
The SPECC1L c.3293G>A (p.Arg1098Gln) variant is a missense variant. The p.Arg1098Gln variant has been reported in one study in which it was identified in a heterozygous state in four individuals from a three generation family and in a heterozygous de novo state in one additional unrelated individual, all affected with SPECC1L-related disorders (Bhoj et al. 2019). The variant is in the calponin-homology domain of the protein, a domain involved in actin-binding. The p.Arg1098Gln variant is not found in the Genome Aggregation Database and is in a region of good sequence coverage, so the variant is presumed to be rare. Pathogenicity of the variant is supported by in silico prediction data. The substitution of arginine for glutamine at this position represents a change in charge. Based on the collective evidence, the p.Arg1098Gln variant is classified as pathogenic for SPECC1L-related syndrome. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at